COO Moves this week include:
|Poseida Therapeutics, Inc.||Halcón Resources Corporation||The Alternative Board|
|GRAIL, Inc.||Tempest Therapeutics, Inc.||ZoomerMedia Limited|
Would you like to receive our weekly COO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.
Should you have any COO Moves to report, please email us.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Poseida Therapeutics, Inc. [SAN DIEGO, CA] announced Kerry Ingalls has joined the company as Chief Operating Officer. Most recently Ingalls was charged with oversight of clinical and commercial manufacturing at Amgen’s headquarters location in Thousand Oaks, California. Previously, Ingalls was responsible for Amgen’s largest manufacturing site.
Halcón Resources Corporation [HOUSTON, TX] announced the appointment of Daniel P. Rohling as Executive Vice President and Chief Operating Officer. Rohling replaces Jon Wright, who previously served in that role. Rohling has approximately 15 years of oil and gas operations experience and was most recently the Asset Vice President at Ajax Resources, LLC. Rohling began his career at EP Energy Corporation as an engineer and held various roles in operations, reservoir engineering, business development and management.
GRAIL, Inc. [MENLO PARK, CA] announced that Matthew P. Young has been appointed Chief Operating Officer and Chief Financial Officer effective October 28, 2019. Young joins GRAIL from Jazz Pharmaceuticals where he most recently served as the company’s Executive Vice President and Chief Financial Officer. Prior to Jazz Pharmaceuticals, Young worked in investment banking for approximately 20 years in positions at Barclays Capital Inc., Citigroup Global Markets Inc., and Lehman Brothers Inc. Currently, Young sits on the board of PRA Health Sciences, Inc., where he currently serves on the compensation and audit committee. Young also serves as Lead Independent Director and Chairman of the audit committee of CytomX Therapeutics, Inc.
Tempest Therapeutics, Inc. [SOUTH SAN FRANCISCO, CA] announced that Stephen Brady has been appointed president and chief operating officer. Most recently, Brady served as executive vice president, strategy and finance at Immune Design. Prior to Immune Design, he held roles of increasing responsibility in multiple biopharmaceutical companies, including as vice president of corporate development at Proteolix.
ZoomerMedia Limited [TORONTO, ON] (TSXV:ZUM) announced the appointment of Dan Hamilton as the Company’s Chief Operating Officer. This is in addition to his existing roles as Chief Revenue Officer and General Manager, Radio.